mu and delta opioid receptors are differentially desensitized by the coexpression of beta-adrenergic receptor kinase 2 and beta-arrestin 2 in Xenopus oocytes

被引:118
作者
Kovoor, A
Nappey, V
Kieffer, BL
Chavkin, C
机构
[1] UNIV WASHINGTON, DEPT PHARMACOL, SEATTLE, WA 98195 USA
[2] UNIV STRASBOURG 1, ECOLE SUPER BIOTECHNOL, F-67085 STRASBOURG, FRANCE
关键词
D O I
10.1074/jbc.272.44.27605
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Xenopus oocyte expression system was used to test the hypothesis that homologous opioid receptor desensitization results from receptor phosphorylation by G protein-coupled receptor kinases. Activation of delta (DOR), mu (MOR) opioid, or beta(2)-adrenergic receptors increased K+ conductance in oocytes coexpressing the G protein-gated inwardly rectifying K+ channel subunits GIRK1 and GIRK4, and the intrinsic rate of desensitization was small. Coexpression of beta-adrenergic receptor kinase 2 (beta-ARK2) and beta-arrestin 2 (beta-arr2) synergistically produced a rapid desensitization of both DOR and beta 2-adrenergic receptor signaling with a t(1/2) < 4 min. beta-ARK2 and beta-arr2 more slowly desensitized MOR responses; a similar synergistic effect on MOR required 2-3 h of agonist treatment. DOR mutants lacking serine and threonine residues at the end of the cytoplasmic tail coupled effectively to GIRK channels but were insensitive to beta-ARK2 and beta-arr2. However, a DOR mutant having serine residues mutated to alanine in the third cytoplasmic loop was indistinguishable in coupling and desensitization from the wild type DOR. These studies establish that opioid receptors can be regulated by beta-ARK2 and beta-arr2 and that a portion of the COOH terminus of DOR enhances sensitivity to this modulation.
引用
收藏
页码:27605 / 27611
页数:7
相关论文
共 47 条
[1]  
Befort K, 1996, MOL PHARMACOL, V49, P216
[2]  
BLANCHARD G, 1988, OPIATE RECEPTORS, P426
[3]   CHRONIC MORPHINE INCREASES MU-OPIATE RECEPTOR-BINDING IN RAT-BRAIN - A QUANTITATIVE AUTORADIOGRAPHIC STUDY [J].
BRADY, LS ;
HERKENHAM, M ;
LONG, JB ;
ROTHMAN, RB .
BRAIN RESEARCH, 1989, 477 (1-2) :382-386
[4]   CNS LEVELS OF MU-OPIOID RECEPTOR (MOR-1) MESSENGER-RNA DURING CHRONIC TREATMENT WITH MORPHINE OR NALTREXONE [J].
BRODSKY, M ;
ELLIOTT, K ;
HYNANSKY, A ;
INTURRISI, CE .
BRAIN RESEARCH BULLETIN, 1995, 38 (02) :135-141
[5]   ENKEPHALIN - RADIOIMMUNOASSAY AND RADIORECEPTOR ASSAY IN MORPHINE-DEPENDENT RATS [J].
CHILDERS, SR ;
SIMANTOV, R ;
SNYDER, SH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 46 (03) :289-293
[6]  
CHRISTIE MJ, 1987, MOL PHARMACOL, V32, P633
[7]   ATRIAL G-PROTEIN-ACTIVATED K+-CHANNEL - EXPRESSION CLONING AND MOLECULAR-PROPERTIES [J].
DASCAL, N ;
SCHREIBMAYER, W ;
LIM, NF ;
WANG, WZ ;
CHAVKIN, C ;
DIMAGNO, L ;
LABARCA, C ;
KIEFFER, BL ;
GAVERIAUXRUFF, C ;
TROLLINGER, D ;
LESTER, HA ;
DAVIDSON, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) :10235-10239
[8]   Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization [J].
Ferguson, SSG ;
Downey, WE ;
Colapietro, AM ;
Barak, LS ;
Menard, L ;
Caron, MG .
SCIENCE, 1996, 271 (5247) :363-366
[9]   G-protein-coupled receptor regulation: Role of G-protein-coupled receptor kinases and arrestins [J].
Ferguson, SSG ;
Barak, LS ;
Zhang, J ;
Caron, MG .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1996, 74 (10) :1095-1110
[10]  
Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319